| 摘要 |
<p>The invention concerns a pharmaceutical composition comprising an Omp membrane protein, in particular an OmpA membrane protein of Klebsiella pneumoniae, associated with lysate of autologous and/or heterologous tumour cells and the use of said compositions for preventing and treating cancer. The invention also concerns a method for isolating tumour antigens using said Omp.</p> |
